Welcome to Thoracic Surgery

lung surgery, stomach surgery, mediastinal surgery, esophageal surgery. cardiothoracic surgery, thoracic surgery

Thoracic Surgery at Weill Cornell Medicine|NewYork-Presbyterian is dedicated to the delivery of the highest quality and advanced care to patients with diseases of the lung, trachea, esophagus, chest wall and mediastinum. Read More.

Learn about the Neuberger Berman Lung Cancer Research Center

NewYork-Presbyterian & Weill Cornell Medicine - Cardiothoracic Surgery

Conditions & Treatments

Our Surgeons

Nasser K. Altorki, M.D.

Jeffrey L. Port, M.D.

Brendon M. Stiles, M.D.

Jonathan Villena-Vargas, M.D.

Sebron W. Harrison, M.D.

Benjamin E. Lee, M.D.

Oliver S. Chow, M.D.

Interventional Pulmonologists

Eugene Shostak, M.D.

FAQs & Patient Guides

Weill Cornell Medicine Cardiothoracic Surgery 525 East 68th Street
Box 110
Suite M 404 New York, NY 10065 Directions
Phone: (212) 746-5166 Email: ctsurgery@med.cornell.edu

News

2nd International Conference Sublobar Resections for Lung Cancer

September 26th, 2019

Griffis Faculty Club - Weill Cornell Medicine

1300 York Avenue

New York, NY 10065

September 27th, 2019

Hosted by AATS

Sheraton New York Times Square Hotel

811 7th Avenue, West 53rd Street

New York, NY 10019

We are pleased to host the 2nd International Conference on Sublobar resections for lung cancer. To register, please click here

Tumor Microenvironments: Mechanisms and Therapeutic Implications 6th Annual Symposium

Gold Nanoparticle Delivery of MicroRNA Impairs Metastasis in Triple-Negative Breast Cancer

lung cancer, thoracic surgery, Neuberger Berman Lung Cancer Research Center, Vivek Mittal

Dr. Vivek Mittal. Credit: John Abbott

Weill Cornell Medicine researchers have shown that giving mice with triple-negative breast cancer therapeutic microRNA (miRNA) in a protective gold nanoparticle results in significantly less spreading of cancer to the lung. Triple-negative breast cancer is a highly aggressive, difficult-to-treat form of the disease, with a high rate of metastatic recurrence. miR-708 is a non-coding microRNA that can block expression of genes that are crucial in metastasis.

To find out more about the article, please click here for details